Articles by Disease (Dyskinesias)

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside

Journal: Current Neuropharmacology
Volume: 17
Page: 861-873
Author(s): Marika Alborghetti and Ferdinando Nicoletti*

Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18
Page: 279-293
Author(s): Laszlo Szpisjak, Denes Zadori, Peter Klivenyi and Laszlo Vecsei*

Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson’s Disease: A Systematic Review

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18
Page: 317-325
Author(s): Mahmoud A. Ebada*, Souad Alkanj, Mohamed Ebada, Ahmed H. Abdelkarim, Ahmed Diab, Mohamed A.E. Aziz, Ahmed M. Soliman, Notila Fayed, Eshak I. Bahbah and Ahmed Negida

Prediction of Ropinirole Urine Level: An Application of the Adaptive-Network-Based Fuzzy Inference System (ANFIS) in Pharmaceutical Analysis

Journal: Current Analytical Chemistry
Volume: 15
Page: 524-530
Author(s): Mahnaz Qomi*, Marjan Gholghasemi, Farhad Azadi and Parviz Raoufi

Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18
Page: 156-169
Author(s): Mona H. Askar, Abdelaziz M. Hussein*, Soheir F. Al-Basiony, Refka K. Meseha, Emile F. Metias, Mohamed M. Salama, Ashraf Antar and Aya El-Sayed

Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18
Page: 11-18
Author(s): Sorabh Sharma, K.C. Sarathlal and Rajeev Taliyan*

Neuroprotective Strategies for Neurological Disorders by Natural Products: An update

Journal: Current Neuropharmacology
Volume: 17
Page: 247-267
Author(s): Muneeb U. Rehman, Adil Farooq Wali, Anas Ahmad, Sheeba Shakeel, Saiema Rasool, Rayeesa Ali, Shazada Mudasir Rashid, Hassan Madkhali, Majid Ahmad Ganaie and Rehan Khan*

Neuroregeneration in Parkinson’s Disease: From Proteins to Small Molecules

Journal: Current Neuropharmacology
Volume: 17
Page: 268-287
Author(s): Yulia A. Sidorova*, Konstantin P. Volcho* and Nariman F. Salakhutdinov

Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease

Journal: Current Neuropharmacology
Volume: 17
Page: 295-306
Author(s): Iván Carrera* and Ramón Cacabelos

Current Limitations in the Treatment of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers

Journal: Current Medicinal Chemistry
Volume: 25
Page: 5755-5771
Author(s): Chiara Tonda-Turo, Nicola Origlia, Clara Mattu, Alice Accorroni and Valeria Chiono*